143 related articles for article (PubMed ID: 37443517)
61. Comparison of clinicopathological features and prognosis of papillary thyroid carcinoma and microcarcinoma: A population-based propensity score matching analysis.
Qian B; Hu L; Zhang S; Zhu J; Mei L; Huang T; Qu X
Front Endocrinol (Lausanne); 2022; 13():944758. PubMed ID: 35992148
[TBL] [Abstract][Full Text] [Related]
62. Natural History of Contralateral Nodules After Lobectomy in Patients With Papillary Thyroid Carcinoma.
Ritter A; Bachar G; Hirsch D; Benbassat C; Katz O; Kochen N; Diker-Cohen T; Akirov A; Shimon I; Robenshtok E
J Clin Endocrinol Metab; 2018 Feb; 103(2):407-414. PubMed ID: 29240898
[TBL] [Abstract][Full Text] [Related]
63. Predictive Factors for Recurrence of Papillary Thyroid Carcinoma in Children and Adolescents.
Gui Y; Huang D; Hou Y; Wei X; Zhang J; Wang J
Front Oncol; 2022; 12():833775. PubMed ID: 35280803
[TBL] [Abstract][Full Text] [Related]
64. High Serum TSH Level Is Associated With Progression of Papillary Thyroid Microcarcinoma During Active Surveillance.
Kim HI; Jang HW; Ahn HS; Ahn S; Park SY; Oh YL; Hahn SY; Shin JH; Kim JH; Kim JS; Chung JH; Kim TH; Kim SW
J Clin Endocrinol Metab; 2018 Feb; 103(2):446-451. PubMed ID: 29211863
[TBL] [Abstract][Full Text] [Related]
65. Serum TSH and risk of papillary thyroid cancer in nodular thyroid disease.
Fiore E; Vitti P
J Clin Endocrinol Metab; 2012 Apr; 97(4):1134-45. PubMed ID: 22278420
[TBL] [Abstract][Full Text] [Related]
66. The natural history of the benign thyroid nodule: what is the appropriate follow-up strategy?
Ajmal S; Rapoport S; Ramirez Batlle H; Mazzaglia PJ
J Am Coll Surg; 2015 Jun; 220(6):987-92. PubMed ID: 25667137
[TBL] [Abstract][Full Text] [Related]
67. Lateral Lymph Node Metastases in T1a Papillary Thyroid Carcinoma: Stratification by Tumor Location and Size.
Zhang X; Chen W; Fang Q; Fan J; Feng L; Guo L; Liu S; Ge H; Du W
Front Endocrinol (Lausanne); 2021; 12():716082. PubMed ID: 34335480
[TBL] [Abstract][Full Text] [Related]
68. lncRNA GAS8-AS1 genetic alterations in papillary thyroid carcinoma and their clinical significance.
Zhou DL; Liu Q; Xu BH; Li Y; Su X; Ye ZL; Zhang X; Peng JL; Deng L; Tang T; Shao Q; Ma JJ; Yang XH; He CY
Cancer Biomark; 2020; 29(2):255-264. PubMed ID: 32675393
[TBL] [Abstract][Full Text] [Related]
69. Endogenous thyrotropin and triiodothyronine concentrations in individuals with thyroid cancer.
Jonklaas J; Nsouli-Maktabi H; Soldin SJ
Thyroid; 2008 Sep; 18(9):943-52. PubMed ID: 18788918
[TBL] [Abstract][Full Text] [Related]
70. Total thyroidectomy with therapeutic level II-IV neck dissection for papillary thyroid carcinoma: level VI recurrence patterns.
Carmel-Neiderman NN; Duek I; Amsterdam D; Wengier A; Kuzmenko B; Ringel B; Warshavsky A; Shapira U; Horowitz G; Izkhakov E; Fliss DM
Eur Arch Otorhinolaryngol; 2020 Dec; 277(12):3449-3455. PubMed ID: 32488373
[TBL] [Abstract][Full Text] [Related]
71. Preoperative subclinical hypothyroidism in patients with papillary thyroid carcinoma.
Ahn D; Sohn JH; Kim JH; Shin CM; Jeon JH; Park JY
Am J Otolaryngol; 2013; 34(4):312-9. PubMed ID: 23357595
[TBL] [Abstract][Full Text] [Related]
72. The Recovery of Thyroid Function in Low-Risk Papillary Thyroid Cancer After Lobectomy: A 3-Year Follow-Up Study.
Dou Y; Chen Y; Hu D; Su X
Front Endocrinol (Lausanne); 2020; 11():619841. PubMed ID: 33633689
[TBL] [Abstract][Full Text] [Related]
73. Thyroid function related symptoms during levothyroxine monotherapy in athyreotic patients.
Ito M; Miyauchi A; Hisakado M; Yoshioka W; Kudo T; Nishihara E; Kihara M; Ito Y; Miya A; Fukata S; Nishikawa M; Nakamura H
Endocr J; 2019 Nov; 66(11):953-960. PubMed ID: 31270299
[TBL] [Abstract][Full Text] [Related]
74. TSH level as a risk factor of thyroid malignancy for nodules in euthyroid patients.
Alaraifi AK; Alessa M; Hijazi LO; Alayed AM; Alsalem AA
Acta Otorhinolaryngol Ital; 2023 Jun; 43(3):183-188. PubMed ID: 37204842
[TBL] [Abstract][Full Text] [Related]
75. Differentiated thyroid cancer in two patients with resistance to thyroid hormone.
Paragliola RM; Lovicu RM; Locantore P; Senes P; Concolino P; Capoluongo E; Pontecorvi A; Corsello SM
Thyroid; 2011 Jul; 21(7):793-7. PubMed ID: 21649470
[TBL] [Abstract][Full Text] [Related]
76. Biochemical Markers Reflecting Thyroid Function in Athyreotic Patients on Levothyroxine Monotherapy.
Ito M; Miyauchi A; Hisakado M; Yoshioka W; Ide A; Kudo T; Nishihara E; Kihara M; Ito Y; Kobayashi K; Miya A; Fukata S; Nishikawa M; Nakamura H; Amino N
Thyroid; 2017 Apr; 27(4):484-490. PubMed ID: 28056660
[TBL] [Abstract][Full Text] [Related]
77. Clinical features of multifocal papillary thyroid carcinoma and risk factors of cervical metastatic lymph nodes.
Ni Y; Wang T; Wang X; Tian Y; Wei W; Liu Q
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 51(2):225-232. PubMed ID: 36161301
[TBL] [Abstract][Full Text] [Related]
78. High Serum Thyrotropin Concentrations within the Reference Range: A Predictor of Malignancy in Nodular Thyroid Disease.
Duccini K; de Souza MVL; Delfim R; Aguiar AP; Teixeira P; Vaisman M
Med Princ Pract; 2018; 27(3):272-277. PubMed ID: 29514150
[TBL] [Abstract][Full Text] [Related]
79. Construction and validation of a nomogram for predicting cervical lymph node metastasis in classic papillary thyroid carcinoma.
Feng Y; Min Y; Chen H; Xiang K; Wang X; Yin G
J Endocrinol Invest; 2021 Oct; 44(10):2203-2211. PubMed ID: 33586026
[TBL] [Abstract][Full Text] [Related]
80. Serum TSH levels are associated with postoperative recurrence and lymph node metastasis of papillary thyroid carcinoma.
Xiang Y; Xu Y; Bhandari A; Sindan N; Hirachan S; Yang Q; Guo G; Shen Y
Am J Transl Res; 2021; 13(6):6108-6116. PubMed ID: 34306349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
